Treatment of BRAFi-R melanoma cells with corin alone or combination treatment with corin plus PLX4032 resulted in up to 75-fold increases in DUSP1 expression compared with treatment with vehicle (Figure 9D and Supplemental Figure 8A). Here, DUSP1 is linked to melanoma.